Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CIS001 Extension Study of Cyclosporine Inhalation Solution (CIS002)

This study has been terminated.
(Parent study CIS001 was completed)
Information provided by (Responsible Party):
APT Pharmaceuticals, Inc. Identifier:
First received: July 9, 2009
Last updated: September 13, 2012
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)